Nov 15 |
Endra Life Sciences GAAP EPS of -$9.54
|
Nov 15 |
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
|
Nov 12 |
Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024
|
Nov 6 |
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent
|
Oct 22 |
Why ENDRA Life Sciences (NDRA) Stock Is Up 140%
|
Oct 22 |
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
|
Oct 3 |
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
|
Oct 2 |
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
|
Aug 30 |
Data I/O And 2 Other Stocks Under $5 Executives Are Buying
|
Aug 28 |
ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements
|